Filing Details

Accession Number:
0001179110-13-016239
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-11-06 16:24:57
Reporting Period:
2013-11-04
Filing Date:
2013-11-06
Accepted Time:
2013-11-06 16:24:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1578845 Actavis Plc ACT Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
925546 L Andrew Turner 1 Grand Canal Square, Docklands
Dublin 2 L2 00000
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2013-11-04 2,677 $156.48 2,764 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.47 to $156.48, inclusive. The reporting person undertakes to provide Actavis plc, any security holder of Actavis plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price range set forth in footnote (1) to this Form 4.